Format

Send to

Choose Destination
See comment in PubMed Commons below
Photodiagnosis Photodyn Ther. 2012 Dec;9(4):287-92. doi: 10.1016/j.pdpdt.2012.03.005. Epub 2012 Aug 30.

Safety and long term efficacy of porfimer sodium photodynamic therapy in locally advanced biliary tract carcinoma.

Author information

1
UCL Institute of Liver and Digestive Health, University College London, UK. stephen.pereira@ucl.ac.uk

Abstract

BACKGROUND:

In patients with unresectable cholangiocarcinoma, photodynamic therapy (PDT) with porfimer sodium promotes biliary drainage and may improve survival and quality of life.

AIM:

To prospectively evaluate the safety and efficacy of PDT in patients with locally advanced biliary tract carcinoma.

METHODS:

Eligible patients had unresectable, histologically confirmed disease, a Karnofsky performance status of ≥30% and life expectancy >12 weeks. Patients received 2mg/kg i.v. of porfimer sodium, followed by endobiliary laser activation and stent replacement 48 h later. Patients were assessed clinically and radiologically before treatment and on day 28, and followed up thereafter at three-monthly intervals until death.

RESULTS:

36 patients were entered over an 18 months period: 14 males, 22 females, with a median age of 65 (30-79)yr and performance status of 80 (50-100). PDT was technically successful in all cases and was generally well tolerated; there was no grade 4 toxicity and no treatment-associated mortality. The median survival was 12 (1-84) months.

CONCLUSIONS:

Porfimer sodium PDT can be delivered safely to patients with biliary tract cancer and is suitable for testing in phase III studies (UKCRN ID 1218).

PMID:
23200007
PMCID:
PMC3513688
DOI:
10.1016/j.pdpdt.2012.03.005
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center